Nonvalvular Cardiovascular Device–Related Infections
暂无分享,去创建一个
Walter R Wilson | Larry M Baddour | A. Jacobs | M. Bettmann | A. Bolger | J. Newburger | R. Baltimore | L. Baddour | S. Shulman | K. Taubert | W. Wilson | P. Ferrieri | M. Gerber | A. Epstein | Alice K Jacobs | Jane W Newburger | Kathryn A Taubert | Ann F Bolger | Stanford T Shulman | Michael A Gerber | Michael H Gewitz | Lloyd Y Tani | Robert S Baltimore | Matthew E Levison | Thomas J Pallasch | Donald A Falace | Michael A Bettmann | Andrew E Epstein | Patricia Ferrieri | M. Levison | M. Gewitz | L. Tani | T. Pallasch | D. Falace | A. Jacobs
[1] Walter R Wilson,et al. Nonvalvular cardiovascular device-related infections. , 2004, Clinical Infectious Diseases.
[2] D. Kovacevich,et al. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[3] C. Brun-Buisson,et al. Nosocomial infections occurring during receipt of circulatory support with the paracorporeal ventricular assist system. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] E. D’Agata. Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] J. Adis,et al. Gladiators: a new order of insect. , 2002, Scientific American.
[6] G. Nassar,et al. Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] M. Back,et al. Management of Vascular Complications following Femoral Artery Catheterization with and without Percutaneous Arterial Closure Devices , 2002, Annals of vascular surgery.
[8] L. Baddour,et al. Nonvalvular intravascular device-related infections , 2002, Current infectious disease reports.
[9] J. Tokars,et al. New national surveillance system for hemodialysis-associated infections: initial results. , 2002, American journal of infection control.
[10] S. Ditlea. The trials of an artificial heart. , 2002, Scientific American.
[11] P. Malani,et al. Nosocomial infections in left ventricular assist device recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] V. Parsonnet,et al. Prophylactic Antibiotics Prior to Bacteremia Decrease Endovascular Graft Infection in Dogs , 2002, Vascular and endovascular surgery.
[13] A. Bolger,et al. Unique features of infective endocarditis in childhood. , 2002, Pediatrics.
[14] A. Bolger,et al. Unique features of infective endocarditis in childhood. , 2002, Circulation.
[15] M. V. van Sambeek,et al. Management of aortic graft infection. , 2002, The Journal of cardiovascular surgery.
[16] M. Shive,et al. Shear stress and material surface effects on adherent human monocyte apoptosis. , 2002, Journal of biomedical materials research.
[17] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[18] U. Steger,et al. Surgical management of prosthetic vascular graft infection: comparative retrospective analysis of 30 consecutive cases. , 2002, VASA. Zeitschrift fur Gefasskrankheiten.
[19] T. Sundt,et al. Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] D. Hudson,et al. The Effectiveness of Muscle Flaps for the Treatment of Prosthetic Graft Sepsis , 2002, Plastic and reconstructive surgery.
[21] J. Duggan,et al. Left Ventricular Assist Device Infections: Three Case Reports and a Review of the Literature , 2002, ASAIO journal.
[22] G. Oderich,et al. Aortic Graft Infection What Have we Learned During the Last Decades ? , 2002, Acta chirurgica Belgica.
[23] S. Kachboura,et al. [Pacemaker infections]. , 2002, La Tunisie medicale.
[24] P. Lang,et al. Closing ventricular septal defects in the cardiac catheterization laboratory. , 2002, Heart disease.
[25] G. Moran,et al. Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, MMWR. Morbidity and mortality weekly report.
[26] J. Eidt,et al. Infectious complications resulting from use of hemostatic puncture closure devices. , 2001, American journal of surgery.
[27] M. Bell. Biofilms: A clinical perspective , 2001, Current infectious disease reports.
[28] J. Elmore,et al. Femoral artery infections associated with percutaneous arterial closure devices. , 2001, Journal of vascular surgery.
[29] R. J. Valentine,et al. Diagnosis and management of aortic graft infection. , 2001, Seminars in vascular surgery.
[30] R. Donlan. Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] J. Keaney. Grossman's cardiac catheterization, angiography, and intervention, 6th ed , 2001 .
[32] L. Danziger,et al. Antimicrobial-Coated/Bonded and -Impregnated Intravascular Catheters , 2001, The Annals of pharmacotherapy.
[33] J. Ruskin,et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. , 2001, The American journal of cardiology.
[34] P. François,et al. Reassessing the Role of Staphylococcus aureus Clumping Factor and Fibronectin-Binding Protein by Expression in Lactococcus lactis , 2001, Infection and Immunity.
[35] L. Baddour. Long‐Term Suppressive Antimicrobial Therapy for Intravascular Device‐Related Infections , 2001, The American journal of the medical sciences.
[36] J. Delcán,et al. Bloodstream infections after invasive nonsurgical cardiologic procedures. , 2001, Archives of internal medicine.
[37] R M Nerem,et al. Endothelial cellular response to altered shear stress. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[38] K. Jenkins,et al. Healing response to the clamshell device for closure of intracardiac defects in humans , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[39] M. Back,et al. Expanded application of in situ replacement for prosthetic graft infection. , 2001, Journal of vascular surgery.
[40] Vance G. Fowler,et al. Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators , 2001, Circulation.
[41] A. Cheung,et al. Adherence Properties of Staphylococcus aureus under Static and Flow Conditions: Roles of agrand sar Loci, Platelets, and Plasma Ligands , 2001, Infection and Immunity.
[42] J. O’Gara,et al. Staphylococcus epidermidis biofilms: importance and implications. , 2001, Journal of medical microbiology.
[43] G. Nassar,et al. Infectious complications of the hemodialysis access. , 2001, Kidney international.
[44] Bunt Tj. Vascular graft infections: an update. , 2001 .
[45] T. Bunt. Vascular Graft Infections: An Update , 2001, Cardiovascular surgery.
[46] M. T. Sykes,et al. Changing Pattern of Access Site Complications with the Use of Percutaneous Closure Devices , 2001, Vascular surgery.
[47] L. Mermel,et al. Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control & Hospital Epidemiology.
[48] D. Botta,et al. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices. , 2001, Journal of vascular surgery.
[49] H. Dosluoglu,et al. Stent-Related Iliac Artery and Iliac Vein Infections: Two Unreported Presentations and Review of the Literature , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[50] F. Bracke,et al. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? , 2001, Heart.
[51] W. C. Sternbergh. Regarding "Dacron carotid patch infection: a report of eight cases". , 2001, Journal of vascular surgery.
[52] M. Oz,et al. Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation. , 2001, Transplantation proceedings.
[53] S Itescu,et al. Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device surface. , 2001, Transplantation proceedings.
[54] H. Scheld,et al. Immunologic effects of implantation of left ventricular assist devices. , 2001, Transplantation proceedings.
[55] P. Grossi,et al. Infectious complications in patients with the Novacor left ventricular assist system. , 2001, Transplantation proceedings.
[56] H. Scheld,et al. Immune response in the early postoperative period after implantation of a left-ventricular assist device system. , 2001, Transplantation proceedings.
[57] D. Raoult,et al. Endocarditis Due to Rare and Fastidious Bacteria , 2001, Clinical Microbiology Reviews.
[58] C. Moore,et al. Complications of femoral artery closure devices , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[59] E. Mylonakis,et al. Infective endocarditis in adults. , 2001, The New England journal of medicine.
[60] N. Aronson,et al. Infected endovascular stents managed with medical therapy alone , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[61] M. Oz,et al. Infections During Left Ventricular Assist Device Support Do Not Affect Posttransplant Outcomes , 2000, Circulation.
[62] L. Horn,et al. Successful retrieval of infected Günther Tulip IVC filter. , 2000, Journal of vascular and interventional radiology : JVIR.
[63] David Longworth,et al. Diagnosis and Management of Infections Involving Implantable Electrophysiologic Cardiac Devices , 2000, Annals of Internal Medicine.
[64] S. Gillespie,et al. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. , 2000, The Journal of infection.
[65] N. Hertzer,et al. Dacron carotid patch infection: a report of eight cases. , 2000, Journal of vascular surgery.
[66] S. Usami,et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[67] S Itescu,et al. Immunobiology of left ventricular assist devices. , 2000, Progress in cardiovascular diseases.
[68] R. Körfer,et al. Complications of circulatory assist , 2000, Perfusion.
[69] J. Fidler,et al. Aortic prosthetic graft infections: radiologic manifestations and implications for management. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.
[70] John M. Tarbell,et al. Interaction between Wall Shear Stress and Circumferential Strain Affects Endothelial Cell Biochemical Production , 2000, Journal of Vascular Research.
[71] M. Höök,et al. The Fibronectin-binding MSCRAMM FnbpA ofStaphylococcus aureus Is a Bifunctional Protein That Also Binds to Fibrinogen* , 2000, The Journal of Biological Chemistry.
[72] D. Grove,et al. Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. , 2000, Journal of Infection.
[73] A. Miller,et al. Infectious complications related to the use of the Angio‐Seal hemostatic puncture closure device , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[74] R. Erbel,et al. Infectious complications related to the use of the Angio‐Seal hemostatic puncture closure device , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[75] Seeger Jm. Management of patients with prosthetic vascular graft infection. , 2000 .
[76] P. Eggimann,et al. Pacemaker and Defibrillator Infections , 2000 .
[77] D. Haas,et al. Antimicrobial Prophylaxis of Infections Associated with Foreign Bodies , 2000 .
[78] J. Seeger. Management of Patients with Prosthetic Vascular Graft Infection , 2000, The American surgeon.
[79] S. Alper,et al. Hemodynamic shear stress and its role in atherosclerosis. , 1999, JAMA.
[80] M. Oz,et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. , 1999, Circulation.
[81] S. Cramton,et al. The Intercellular Adhesion (ica) Locus Is Present in Staphylococcus aureus and Is Required for Biofilm Formation , 1999, Infection and Immunity.
[82] J M Anderson,et al. Shear stress effects on bacterial adhesion, leukocyte adhesion, and leukocyte oxidative capacity on a polyetherurethane. , 1999, Journal of biomedical materials research.
[83] R. Welling,et al. Infectibility of endovascular stents following antibiotic prophylaxis or after arterial wall incorporation. , 1999, American journal of surgery.
[84] Silviu Itescu,et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice , 1999, The Lancet.
[85] R. Benza,et al. Infection during circulatory support with ventricular assist devices. , 1999, The Annals of thoracic surgery.
[86] J. Robin,et al. Video-assisted tricuspid valve surgery: a new surgical option in endocarditis on pacemaker. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[87] O. Berenfeld,et al. Cardiopulmonary interactions after Fontan operations. , 1999, Circulation.
[88] Y. Han,et al. New self‐expanding patent foramen ovale occlusion device , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[89] M. Turina,et al. Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts. , 1999, The Annals of thoracic surgery.
[90] T. Deneke,et al. Suppurative pancarditis: a lethal complication of coronary stent implantation , 1999, Heart.
[91] M. Kerstein,et al. Management of Vascular Prosthetic Infections: Results of Long-Term Follow-up , 1999, The American surgeon.
[92] T. Horan,et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. , 1999, American journal of infection control.
[93] Teresa C. Horan,et al. Guideline for Prevention of Surgical Site Infection, 1999 , 1999, Infection Control & Hospital Epidemiology.
[94] A. Irvine,et al. Infection of endovascular stents: an uncommon but important complication. , 1999, Cardiovascular surgery.
[95] S. Menahem,et al. Infective endocarditis on an occluder closing an atrial septal defect , 1999, Cardiology in the Young.
[96] H Le Breton,et al. Pacemaker lead infection: echocardiographic features, management, and outcome , 1999, Heart.
[97] T. Horan,et al. Guideline for prevention of surgical site infection. , 2000, Bulletin of the American College of Surgeons.
[98] Ò. Miró,et al. Pacemaker-Related Endocarditis , 1999, Cardiology.
[99] P. Holme,et al. Shear-induced platelet activation and platelet microparticle formation in native human blood. , 1998, Thrombosis research.
[100] G. Lamas,et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. , 1998, The American journal of cardiology.
[101] R. Kontermann,et al. Cloning and recombinant expression of mouse coagulation factor X. , 1998, Thrombosis research.
[102] A. Pavie,et al. Pacemaker infective endocarditis. , 1998, The American journal of cardiology.
[103] K. K. Lai,et al. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[104] T. Jikuya,et al. Prevention of pulmonary embolization during excision of an infected venous thrombus. , 1998, The Thoracic and cardiovascular surgeon.
[105] A. Natale,et al. Causes and consequences of discontinuation of the implantable cardioverter-defibrillator therapy in non-terminally ill patients. , 1998, The American journal of cardiology.
[106] K Isaaz,et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. , 1998, Circulation.
[107] E. Sideris,et al. Intermediate-term results of Phase I Food and Drug Administration Trials of buttoned device occlusion of secundum atrial septal defects. , 1998, Journal of the American College of Cardiology.
[108] A. Garson,et al. Pediatric therapeutic cardiac catheterization: a statement for healthcare professionals from the Council on Cardiovascular Disease in the Young, American Heart Association. , 1998, Circulation.
[109] Ò. Miró,et al. Pacemaker-related endocarditis. Report of 7 cases and review of the literature. , 1998, Cardiology.
[110] L. Latson. Per-Catheter ASD Closure , 1998, Pediatric Cardiology.
[111] J. Berland,et al. Pseudomonas aeruginosa coronary stent infection. , 1997, The Annals of thoracic surgery.
[112] M. Oz,et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[113] A F Bolger,et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. , 1997, Circulation.
[114] D Lacroix,et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. , 1997, Circulation.
[115] M H Samore,et al. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. , 1997, The American journal of cardiology.
[116] H. Scheld,et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. , 1997, Circulation.
[117] P. Pairolero,et al. Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. , 1997, Journal of vascular surgery.
[118] G. Trenholme,et al. Infectious complications in left ventricular assist device recipients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[119] A. Prat,et al. Fatal infection of coronary stent implantation. , 1996, Catheterization and cardiovascular diagnosis.
[120] T. Myers,et al. Retrospective analysis of infection in patients undergoing support with left ventricular assist systems. , 1996, ASAIO journal.
[121] R. Vogelzang,et al. Endovascular infection after renal artery stent placement. , 1996, Journal of vascular and interventional radiology : JVIR.
[122] A. Heimdahl,et al. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. , 1996, The Journal of infectious diseases.
[123] D. Mack,et al. Molecular basis of intercellular adhesion in the biofilm‐forming Staphylococcus epidermidis , 1996, Molecular microbiology.
[124] P. McCarthy,et al. Implantable LVAD infections: implications for permanent use of the device. , 1996, The Annals of thoracic surgery.
[125] A. Bisno,et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. , 1995, JAMA.
[126] P. François,et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis , 1995, Infection and immunity.
[127] M. Oz,et al. Fungal Infections in Left Ventricular Assist Device Recipients: Incidence, Prophylaxis, and Treatment , 1995, ASAIO journal.
[128] B. Cunha,et al. Bacteremia associated with percutaneous transluminal coronary angioplasty. , 1995, Catheterization and cardiovascular diagnosis.
[129] H. Trappe,et al. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. , 1995, British heart journal.
[130] M. Gilchrist. Recommendations for Preventing the Spread of Vancomycin Resistance , 1995, Infection Control & Hospital Epidemiology.
[131] S. Einav,et al. Transition to turbulence in pulsatile flow through heart valves--a modified stability approach. , 1994, Journal of biomechanical engineering.
[132] I. Lossos,et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. , 1994, Medicine.
[133] G. Hausdorf,et al. International experience with secundum atrial septal defect occlusion by the buttoned device. , 1994, American heart journal.
[134] I Vilacosta,et al. Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study , 1994 .
[135] R. Wenzel,et al. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures , 1994, Infection Control & Hospital Epidemiology.
[136] D. Moher,et al. LGM (Vena Tech) vena caval filter: experience at a single institution. , 1994, Journal of vascular and interventional radiology : JVIR.
[137] M. Hravnak,et al. Management of chronic left ventricular assist device percutaneous lead insertion sites. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[138] T. Bonzel,et al. [Coronary stent implantation: infection and abscess with fatal outcome]. , 1993, Zeitschrift fur Kardiologie.
[139] D. Pittet,et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. , 1993, The Journal of infectious diseases.
[140] P. Ferrieri,et al. Laboratory diagnostic methods for central nervous system infections. , 1992, Neurosurgery clinics of North America.
[141] B. Guglielmo,et al. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. ASHP Commission on Therapeutics. , 1992, Clinical pharmacy.
[142] J. Fehrenbacher,et al. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. , 1991, Journal of vascular surgery.
[143] T. Myers,et al. Frequency and significance of infections in patients receiving prolonged LVAD support. , 1991, ASAIO transactions.
[144] D. Pennington,et al. Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days. , 1991, ASAIO transactions.
[145] L. Ong,et al. Local infection after percutaneous transluminal coronary angioplasty: relation to early repuncture of ipsilateral femoral artery. , 1989, Catheterization and cardiovascular diagnosis.
[146] B. Griffith,et al. Infections and thromboembolism with implantable cardiovascular devices. , 1989, ASAIO transactions.
[147] A. Pavie,et al. Total artificial heart: survival and complications. , 1989, The Annals of thoracic surgery.
[148] F. Loop,et al. Infections of the cardiac suture line after left ventricular surgery. , 1988, The American journal of medicine.
[149] W. Rutala,et al. An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. , 1988, The Journal of thoracic and cardiovascular surgery.
[150] R L Kormos,et al. The artificial heart: infection-related morbidity and its effect on transplantation. , 1988, The Annals of thoracic surgery.
[151] L. Rice,et al. Artificial heart implantation: what limitations are imposed by infectious complications? , 1988, JAMA.
[152] M. Rubenfire,et al. Intraaortic balloon pump insertion: a randomized study comparing percutaneous and surgical techniques. , 1987, Journal of the American College of Cardiology.
[153] L. R. Freedman. The pathogenesis of infective endocarditis. , 1987, The Journal of antimicrobial chemotherapy.
[154] M. Rubenfire,et al. Intraaortic balloon pumping 1967 through 1982: analysis of complications in 733 patients. , 1986, The American journal of cardiology.
[155] G. Magovern,et al. Is percutaneous insertion of the intra-aortic balloon pump through the femoral artery the safest technique? , 1986, Journal of vascular surgery.
[156] G. Bluhm. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. , 2009, Acta medica Scandinavica. Supplementum.
[157] E. B. Carlson,et al. Interventional cardiac catheterization. , 1985, Investigative radiology.
[158] H. Bolooki. Current status of circulatory support with an intra-aortic balloon pump. , 1985, Cardiology clinics.
[159] D. Bandyk,et al. Aortofemoral graft infection due to Staphylococcus epidermidis. , 1984, Archives of surgery.
[160] J. Vildé,et al. [Lumbar spondylodiscitis after insertion of a Mobin-Uddin caval "umbrella" filter (author's transl)]. , 1981, La Nouvelle presse medicale.
[161] C. Marseille. Antimicrobial prophylaxis for surgery. , 1981, The Medical letter on drugs and therapeutics.
[162] D. Maki,et al. Infections Caused by Arterial Catheters Used for Hemodynamic Monitoring , 1980 .
[163] V L Gott,et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.
[164] C. Friedman,et al. Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. , 1980, Annals of internal medicine.
[165] L. Edmunds,et al. The Intraaortic Balloon Pump: An Analysis of Five Years' Experience , 1980 .
[166] J. C. Norman,et al. Treatment of postoperative low output syndrome with intraaortic balloon pumping: experience with 419 patients. , 1980, The American journal of cardiology.
[167] W. Casarella,et al. Percutaneous intraaortic balloon pumping: initial clinical experience. , 1980, The Annals of thoracic surgery.
[168] S. I. Cohen,et al. Medically refractory unstable angina pectoris. I. Long-term follow-up of patients undergoing intraaortic balloon counterpulsation and operation. , 1979, The American journal of cardiology.
[169] V. Subramanian,et al. Complications of Intra-aortic Balloon Insertion and Counterpulsation , 1978, Circulation.
[170] R. Mabel,et al. Complications of intra-aortic balloon insertion and counterpulsation. , 1978 .
[171] A. Baue,et al. Results and complications of intraaortic balloon counterpulsation. , 1977, The Annals of thoracic surgery.
[172] M. Levison,et al. Sustained bacteremia and transvenous cardiac pacemakers. , 1975, JAMA.
[173] T. Nealon,et al. Four hundred consecutive patients with permanent transvenous pacemakers. , 1975, The Journal of thoracic and cardiovascular surgery.
[174] H. Gold,et al. Intraaortic Balloon Pumping for Ventricular Septal Defect or Mitral Regurgitation Complicating Acute Myocardial Infarction , 1973, Circulation.
[175] A. Kantrowitz,et al. Clinical and Hemodynamic Results of Intraaortic Balloon Pumping and Surgery for Cardiogenic Shock , 1972, Circulation.
[176] I. Schwartz,et al. Bacterial endocarditis associated with a permanent transvenous cardiac pacemaker. , 1971, JAMA.
[177] G. Rowe. Complications of cardiac catheterization. , 1971, Wisconsin medical journal.
[178] Swan Hj. Complications of cardiac catheterization. , 1968, Cardio-vascular nursing.
[179] A Kantrowitz,et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. , 1968, JAMA.
[180] Jane M. KUYPERSlt,et al. Reduced Adherence to Traumatized Rat Heart Valves by a Low-Fibronectin-Binding Mutant of Staphylococcus aureus , 2022 .